TROIKA‐1: A double‐blind, randomized, parallel group, study aimed to demonstrate the equivalent pharmacokinetic profile of HD201, a potential biosimilar candidate to trastuzumab, v...

por Demarchi, Martin, Coliat, Pierre, Mclendon, Kristi, Chung Shii Hii, Jocelyn, Feyaerts, Peggy, Ang, Felicia, Jaison, Litha, Deforce, Filip, Derde, Marie Paule, Kim, Michael Jinwoo, Park, Lisa Soyeon, Detappe, Alexandre, Pivot, Xavier
Publicado 2021